"Hypoxia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Sub-optimal OXYGEN levels in the ambient air of living organisms.
| Descriptor ID |
D000860
|
| MeSH Number(s) |
C23.888.852.079
|
| Concept/Terms |
Hypoxia- Hypoxia
- Oxygen Deficiency
- Deficiency, Oxygen
- Deficiencies, Oxygen
- Oxygen Deficiencies
|
Below are MeSH descriptors whose meaning is more general than "Hypoxia".
Below are MeSH descriptors whose meaning is more specific than "Hypoxia".
This graph shows the total number of publications written about "Hypoxia" by people in this website by year, and whether "Hypoxia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2000 | 2 | 0 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 2 | 1 | 3 |
| 2007 | 1 | 2 | 3 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 3 | 2 | 5 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2013 | 0 | 5 | 5 |
| 2014 | 1 | 1 | 2 |
| 2015 | 3 | 1 | 4 |
| 2016 | 3 | 4 | 7 |
| 2017 | 59 | 40 | 99 |
| 2018 | 51 | 48 | 99 |
| 2019 | 23 | 15 | 38 |
| 2020 | 48 | 66 | 114 |
| 2021 | 20 | 45 | 65 |
To return to the timeline, click here.
Below are the most recent publications written about "Hypoxia" by people in Profiles.
-
Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis. Shock. 2022 01 01; 57(1):1-6.
-
Is carbonic anhydrase inhibition useful as a complementary therapy of Covid-19 infection? J Enzyme Inhib Med Chem. 2021 Dec; 36(1):1230-1235.
-
Platypnoea-orthodeoxia syndrome in an older patient with COVID-19 pneumonia and orthostatic hypotension-a case of prolonged hospital admission. Age Ageing. 2021 11 10; 50(6):1886-1887.
-
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: The COVID STEROID randomised, placebo-controlled trial. Acta Anaesthesiol Scand. 2021 11; 65(10):1421-1430.
-
Severe fetal brain damage subsequent to acute maternal hypoxemic deterioration in COVID-19. Ultrasound Obstet Gynecol. 2021 09; 58(3):490-491.
-
Can We Reliably Predict the Failure of Noninvasive Ventilation in COVID-19-associated Acute Hypoxemic Respiratory Failure? Ann Am Thorac Soc. 2021 09; 18(9):1595.
-
Reply: Can We Reliably Predict the Failure of Noninvasive Ventilation in COVID-19-associated Acute Hypoxemic Respiratory Failure? Ann Am Thorac Soc. 2021 09; 18(9):1595-1596.
-
Rationale and Design of the Awake Prone Position for Early Hypoxemia in COVID-19 Study Protocol: A Clinical Trial. Ann Am Thorac Soc. 2021 09; 18(9):1560-1566.
-
Upregulation of FOXP3 is associated with severity of hypoxia and poor outcomes in COVID-19 patients. Virology. 2021 11; 563:74-81.
-
Association of rs11549465 (C1772T) variant of hypoxia-inducible factor-1a with Covid-19 susceptibility. A population-based epidemiological study. Hum Cell. 2021 Nov; 34(6):1937-1940.